stage

AIN
Exymes PLC

Exymes PLC

location_on 东南 ,  英国

请注意：
投资于早期阶段的企业存在风险，包括流动性不足、无分红、投资损失及股权稀释等。因此，此类投资应仅作为多元化投资组合的一部分进行。本平台仅面向具备足够专业知识、能够理解相关风险并自行作出投资决策的投资者。我们鼓励投资者自行审阅与评估各项投资，并根据自身判断决定是否参与。本网站所提供的信息仅供参考，我们无法保证其准确性或完整性。我们强烈建议投资者在进行任何投资前，与持牌专业人士完成尽职调查。本平台不提供任何法律或税务方面的建议。

简要概述

Enzymatic fast release of stable, patentable and downstreamable DNA and RNA in under 10 minutes. The current annual market size is $1.28 billion.

亮点

  • Already have accepted products and repeat customers.
  • Excellent highly experienced recognised international team.
  • Already have some very credible high profile respected repeat customers
  • Extremely high margin repeat products
  • All current team members shareholders

概览

目标 HK$ 21,000,000
最低标准。 HK$ 275,000
融资已到位。 HK$ 4,200,000
过往融资轮次 HK$ 4,200,000
阶段 实现销售
投资人角色 安静。

提出一个问题。
有問題嗎？

相似项目

Enertor Insoles

Enertor Insoles

location_on东安格利亚, 英国

Transform sports recovery & performance with Enertor's PX1® insoles—revolutionary technology reducing impact by 51%. Endorsed by Usain Bolt, we aim to be the next £1B brand. Invest in innovation redefining running and injury prevention. Raised £330K✅

  • 69% injury reduction proven in clinical trials with British Army
  • Endorsed by Usain Bolt; trusted by elite athletes worldwide
  • Rated best insoles by The New York Times and Runner's World

HK$3,200,000

融资目标

HK$55,000

最低投资额
了解更多
BBKItty: Baby Comfort

BBKItty: Baby Comfort

location_on吕宋, 菲律宾

BB Kitty is the first diaper brand in the Philippines to sell per piece; We cater to Filipinos’ “try first” buying behavior and affordability concerns. Our eCommerce & retail strategy makes premium diapers accessible to all.

  • First diaper brand selling per piece in the Philippines.
  • Massive demand – ₱58B market with 1.85M+ births yearly.
  • Affordable premium brand disrupting a bulk-pack industry.

HK$1,400,000

融资目标

HK$15,000

最低投资额
了解更多
Entac Medical Inc.

Entac Medical Inc.

location_on东南, 美国

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

  • PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
  • In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
  • Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.

HK$16,000,000

融资目标

HK$400,000

最低投资额
了解更多
Loading…
Loading the web debug toolbar…
Attempt #